BIOMERICA INC
$2.36
-$0.01 (-0.42%)
$2.26Day Range$2.41
Key Statistics
Market Cap
$10.83M
Shares Outstanding
4.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 26, 1978
Round Lot
100
Locale
US
Trading Data
Day Open
$2.31
Day High
$2.41
Day Low
$2.26
Volume
37.7K
VWAP
$2.33
Prev Close
$2.37
Transactions
--
Acc. Volume
--
About BIOMERICA INC
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESSIC 283550 employees17571 VON KARMAN AVENUE, IRVINE, CA, 92614(949) 379-2875IPO Sep 26, 1978US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000073290
- Composite FIGI
- BBG000BDH8F6
- Share Class FIGI
- BBG001S5P8X4
- Ticker Root
- BMRA
- SIC Code
- 2835
About BIOMERICA INC (BMRA) Stock
BIOMERICA INC (BMRA) closed the 2026-09-17 session at $2.36, down 0.42% versus the previous close (-0.01). The stock opened at $2.31 and traded between $2.26 and $2.41 during that session. Session trading volume was 38K shares. The volume-weighted average price (VWAP) is $2.33.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.
BIOMERICA INC has a market capitalization of $10.8 million. The company operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry classification. BMRA is listed on the XNAS exchange. The company employs approximately 50 people. BIOMERICA INC is headquartered in IRVINE, CA. The recorded listing date is 1978-09-26.
On this page you can find market BMRA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.